NANBIOSIS attended a specialized course on patent strategy and industrial property, strengthening its expertise in research valorization, technology transfer, and innovation management.
Zaragoza, July 2026 — From 2 to 3 July 2026, NANBIOSIS participated in the course “Estrategia de Patentes y Propiedad Industrial: De la Investigación a la Transferencia Global“, held at the University of Zaragoza, in the context of the Extraordinary Summer Courses 2026.
Coordinated by Ana Gil Lacruz (University of Zaragoza) and Manuel Moreno-Torres Sánchez (Bufete Moreno Torres SLP), the two-day course provided practical training for researchers, innovation managers, and technology transfer professionals on how to identify, protect, and leverage industrial property assets in international markets.
The programme covered the full innovation pathway, from evaluating research results and patentability to managing intellectual property portfolios and reducing legal risks in global commercialization. Participants also explored advanced patent search techniques using WIPO PATENTSCOPE and the European Patent Office’s Espacenet database, as well as strategies for technology intelligence, freedom-to-operate analyses, patent landscape assessment, and dispute resolution through the World Intellectual Property Organization (WIPO).
The course featured contributions from experts from the University of Zaragoza, WIPO, industry representatives, patent specialists, and legal professionals, offering participants a comprehensive perspective on the role of industrial property in research commercialization and international technology transfer.
The course was closed dwon by Begoña Pérez Calle, professor of Universidad de Zaragoza and Delegate of the Rector for Extraordinary Courses.
By attending this training, NANBIOSIS continues to strengthen its understanding of innovation management and intellectual property, reinforcing its commitment to supporting researchers and fostering the translation of scientific knowledge into societal and economic value.
What is NANBIOSIS?
The goal of NANBIOSIS is to provide comprehensive and integrated advanced solutions for companies and research institutions in biomedical applications. All of this is done through a single-entry point, involving the design and production of biomaterials, nanomaterials, and their nanoconjugates. This includes their characterization from physical-chemical, functional, toxicological, and biological perspectives (preclinical validation).
If you want to collaborate with us, visit our Order Request page.
In order to access our Cutting-Edge Biomedical Solutions with priority access, enter our Competitive Call here.
NANBIOSIS has worked with pharmaceutical companies of all sizes in the areas of drug delivery, biomaterials and regenerative medicine. Here are a few of them:
